Our findings are consistent with a study on OV-related CCA cells and epidermal growth factor receptor (EGFR) kinase inhibitors, suggesting that drug sensitivity does not consistently correlate with EGFR expression levels [37]. The gene discussed is EGFR; the disease is cholangiocarcinoma.